Mpox vaccination rates for Black and Hispanic men during the height of the mpox outbreak in 2022 were higher as compared to White men, reflecting effective vaccination campaigns, but the impact was essentially outweighed given disproportionately high Mpox incidence among minority males.
Those findings are summarized in an April 2023 MMWR, Racial and Ethnic Disparities in Mpox Cases and Vaccination Among Adult Males — United States, May–December 2022. The study also summarized Mpox case data for: "May 10–December 31, 2022, a total of 27,946 mpox cases were reported among males aged ≥18 years, including 30.7% in Black males, 29.5% in Hispanic males, and 27.9% in White males."
Daily Mpox cases have dropped 97%, compared to peaks in 2022, resulting in a an end to the Mpox emergency declaration. A high proportion of mpox cases occurred among people with HIV or STIs.
Access HRSA's Mpox Information webpage and our resources on Sexually Transmitted Infections.